Abdominal scintigraphy using technetium Tc 99m hexylmethylpropylene amine oxime-labeled leukocytes in patients with seronegative spondyloarthropathies

Seminars in Arthritis and Rheumatism

Volumn 31, Issue 6, 2002, Pages 406-412

  Elkayam, Ori ^a   Paran, Daphna ^a   Even Sapir, Einat ^a   Litinsky, Irena ^a   Wigler, Irena ^a   Yaron, Michael ^a   Caspi, Dan ^b,c  

^a Department of Rheumatology ^*  (Israel)

^b Day Care Rheumatology Unit

^c TEL AVIV UNIVERSITY   (Israel)

Author keywords

Crohn's disease; Inflammatory bowel disease; Spondyloarthropathy; Tc 99m HMPAO

Indexed keywords

HEXAMETHYLPROPYLENE AMINE OXIME TECHNETIUM TC 99M; SALAZOSULFAPYRIDINE;

ABDOMINAL SCINTISCANNING; ADOLESCENT; ADULT; ARTICLE; BARIUM ENEMA; CLINICAL ARTICLE; CLINICAL EXAMINATION; COLONOSCOPY; CROHN DISEASE; DIFFERENTIAL DIAGNOSIS; ENTERITIS; FEMALE; GASTROINTESTINAL SYMPTOM; HUMAN; LABORATORY DIAGNOSIS; LEUKOCYTE; MALE; PRIORITY JOURNAL; SPONDYLOARTHROPATHY;

EID: 0036301297     PISSN: 00490172     EISSN: None     Source Type: Journal    
DOI: 10.1053/sarh.2002.32550     Document Type: Article

References (24)

1. Spondyloarthropathy, undifferentiated spondyloarthritis, and overlap
2. Gut inflammation in the spondyloarthropathies: Clinical, radiological, biologic, and genetic features in relation to the type of histology: A prospective study
3. Diagnostic approach to inflammatory bowel disease
4. The evolution of spondyloarthropathies in relation to gut histology. II. Histological aspects
5. Interobserver variation in describing endoscopic features in inflammatory bowel disease using videotapes of colonoscopy
6. Labeled leukocyte scintigraphy in inflammatory bowel disease: Clinical applications
7. Inflammation: Imaging with Tc-99m HMPAO-labeled leukocytes
8. 99mTc-HMPAO imaging in Crohn's disease of the small bowel
9. Scintigraphic assessment of bowel involvement and disease activity in Crohn's disease using Tc-99m HMPAO as a leukocyte label
10. Abdominal scintigraphy using 99mTc-HMPAO-labeled leukocytes in patients with seronegative spondyloarthropathies without clinical evidence of inflammatory bowel disease
11. The European Spondyloarthropathy Study Group preliminary criteria for the classification of spondyloarthropathy
12. Inflammatory bowel disease activity assessment using technecium-99m-HMPAO leukocytes
13. Value of technecium-99m HMPAO-labelled leukocyte scintigraphy as an initial screening test in patients suspected of having inflammatory bowel disease
14. Optimization of technecium-99m-HMPAO leukocyte scintigraphy in evaluation of active inflammatory bowel disease
15. The role of nuclear medicine in inflammatory bowel disease. A review with experiences of aseptic bowel activity using immunoscintigraphy with 99mTc anti-granulocyte antibodies
16. The technecium white cell scan as an initial imaging investigation for evaluating suspected childhood inflammatory bowel disease
17. The evolution of spondyloarthropathies in relation to gut histology. I. Clinical aspects
18. The evolution of spondyloarthropathies in relation to gut histology III. Relation between gut and joint
19. Long-term evolution of gut inflammation in patients with spondyloarthropathy
20. Microscopic inflammatory changes in colon of patients with both active psoriasis and psoriatic arthritis without bowel symptoms
21. Inflammatory disease in HLA-B27 transgenic rats
22. Different abdominal scintigraphy pattern in patients with ulcerative colitis, Crohn's disease and seronegative spondyloarthropathy
23. Concordance between abdominal scintigraphy using technetium-99m hexamethylpropylene amine oxime-labeled leukocytes and ileocolonoscopy in patients with spondyloarthropathies and without clinical evidence of inflammatory bowel disease
24. Evidence of subclinical intestinal inflammation by 99m technetium leukocyte scintigraphy in patients with HLA-B27 positive juvenile onset active spondyloarthropathy